| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.31B | 1.33B | 1.21B | 1.12B | 1.12B |
| Gross Profit | 281.76M | 309.68M | 304.66M | 260.89M | 335.36M |
| EBITDA | 58.81M | -23.41M | 98.21M | 72.41M | 47.44M |
| Net Income | -51.05M | -12.07M | 57.13M | 41.34M | 35.47M |
Balance Sheet | |||||
| Total Assets | 1.58B | 1.68B | 1.47B | 1.37B | 1.36B |
| Cash, Cash Equivalents and Short-Term Investments | 724.70M | 738.08M | 565.90M | 538.50M | 628.31M |
| Total Debt | 2.83M | 2.65M | 0.00 | 0.00 | 20.51M |
| Total Liabilities | 979.77M | 1.01B | 758.07M | 694.90M | 684.35M |
| Stockholders Equity | 537.62M | 619.21M | 657.49M | 629.28M | 637.48M |
Cash Flow | |||||
| Free Cash Flow | 8.38M | 10.28M | 82.97M | -21.47M | -7.33M |
| Operating Cash Flow | 13.54M | 25.50M | 93.39M | -12.41M | 1.24M |
| Investing Cash Flow | 26.85M | -77.65M | 50.09M | -17.55M | -192.10M |
| Financing Cash Flow | -35.12M | -21.61M | -35.27M | -84.77M | -39.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$519.95M | 6.14 | 11.59% | ― | 1.82% | -2.78% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
59 Neutral | HK$229.15M | 6.11 | -0.02% | ― | -68.21% | -100.40% | |
54 Neutral | HK$210.61M | 5.65 | 4.23% | 6.60% | -9.97% | -46.38% | |
51 Neutral | HK$221.52M | -3.79 | -8.93% | 15.45% | 1.07% | -1080.00% | |
43 Neutral | HK$172.80M | 13.70 | 2.10% | ― | -6.51% | 512.50% |